BSE filing, BSE: 544191. Summary written from the filing by ALFA Finder's alert engine.
Purple Finance Ltd: key numbers
- Share price
- ₹63.51
- Market cap
- ₹489.9 Cr
- Revenue (annual)
- ₹47.65 Cr
- Net profit (annual)
- ₹-6.44 Cr
- P/E (TTM)
- -198.4×Sector 19.7×
- Promoter holding
- 35.56%+11.10% QoQ
- FII holding
- 0.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Purple Finance Ltd
All →Purple Finance Debt & Borrowing: ₹0.16 Cr
Purple Finance paid Rs 16.44 lakh interest on its secured NCDs on the due date, October 26, 2026. TDS was deducted as per applicable law.
- Value
- ₹0.16 Cr
Purple Finance Business Update
Purple Finance plans to enter affordable housing finance and launched two new MSME-focused lending products, while sharing operational performance updates and financial highlights.
Purple Finance Q2 FY27 Results: Turns Profitable, Net Profit ₹1 Cr
Purple Finance Ltd reported revenue from operations of ₹17.3 Cr (+55.9% YoY) and net profit of ₹1 Cr for Q2 FY27.
- Key figure
- Net profit ₹1 Cr
Purple Finance Employee Stock Options
Purple Finance allotted 5,000 equity shares to employees upon ESOP exercise at Rs. 33 per share. Paid-up capital increased to 7.71 crore shares.
Purple Finance Other Announcement
Purple Finance Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulation.
Purple Finance Debt & Borrowing: ₹0.17 Cr
Purple Finance Ltd successfully paid Rs.0.17 Crore as interest on its non-convertible debentures for the period ending October 2026.
- Value
- ₹0.17 Cr
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.